Determinants of Quality of Life Related to Health in Alzheimer Disease

Alzheimer Disease Clinical Trial

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT01570322
• Other study ID #: PN09004
• Status: Recruiting
• Phase: N/A
• First received: April 2, 2012
• Last updated: June 8, 2016

Study information

• Verified date: June 2016
• Source: CHU de Reims
• Contact: Jean-Luc NOVELLA, MD PhD
• Email: jlnovella[@]chu-reims.fr
• Is FDA regulated: No
• Health authority: France: Ministry of Health
• Study type: Observational

Clinical Trial Summary

Study the factors that explain Health-Related Quality of Life (HRQL) in patients with Alzheimer disease including:

• The influence of the environment (physical and human) on Health-Related Quality of Life (HRQL),

• The influence of non-drug and drug treatments on Health-Related Quality of Life (HRQL),

• The influence of formal and informal help mobilized,

• The influence of interactions "patient - caregiver" on Health-Related Quality of Life (HRQL),

• The influence of the ratio necessary cost on available resources on Health-Related Quality of Life (HRQL)

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 400
• Accepts healthy volunteers: No
• Gender: Both
• Age group: 75 Years and older

Eligibility

Inclusion Criteria:

• Patients with Alzheimer disease (DSM IV and NINCDS-ADRDA)

• Patients with MMSE (Mini Mental State Examination) > or = 10

• Out patients

Exclusion Criteria:

• Severe sensory disturbances,

• Non French speaking

Study Design

Observational Model: Cohort, Time Perspective: Prospective

Related Conditions & MeSH terms

• Alzheimer Disease

Locations

Country	Name	City	State
France	CHU de REIMS	Reims

Sponsors (1)

Lead Sponsor	Collaborator
CHU de Reims

Country where clinical trial is conducted

France, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Health-Related Quality of Life (HRQOL) Assessment